These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3966714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
    Ganey PE, Roth RA.
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
    Gillespie MN, Olson JW, Reinsel CN, O'Connor WN, Altiere RJ.
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H109-14. PubMed ID: 2942040
    [Abstract] [Full Text] [Related]

  • 6. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS, Bell TG, Lorimer D, Roth RA.
    Am J Physiol; 1984 Jun; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [Abstract] [Full Text] [Related]

  • 7. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices.
    Hilliker KS, Garcia CM, Roth RA.
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):179-97. PubMed ID: 6410470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
    Ganey PE, Roth RA.
    Exp Lung Res; 1987 May; 12(3):195-206. PubMed ID: 3107969
    [Abstract] [Full Text] [Related]

  • 10. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
    Ganey PE, Roth RA.
    Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
    Ganey PE, Sprugel KH, White SM, Wagner JG, Roth RA.
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
    [Abstract] [Full Text] [Related]

  • 12. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
    Gillespie MN, Dyer KK, Olson JW, O'Connor WN, Altiere RJ.
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
    [Abstract] [Full Text] [Related]

  • 13. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
    Hilliker KS, Roth RA.
    Exp Lung Res; 1985 Dec; 8(4):201-12. PubMed ID: 4043006
    [Abstract] [Full Text] [Related]

  • 14. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury.
    Bruner LH, Johnson KJ, Till GO, Roth RA.
    Am J Physiol; 1988 Feb; 254(2 Pt 2):H258-64. PubMed ID: 3344816
    [Abstract] [Full Text] [Related]

  • 15. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
    Pan LC, Wilson DW, Segall HJ.
    Toxicology; 1993 Mar 30; 79(1):21-35. PubMed ID: 8475497
    [Abstract] [Full Text] [Related]

  • 16. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1989 Jun 15; 99(2):302-13. PubMed ID: 2734793
    [Abstract] [Full Text] [Related]

  • 17. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
    Roth RA, Ganey PE.
    Toxicol Appl Pharmacol; 1988 May 15; 93(3):463-71. PubMed ID: 3130680
    [Abstract] [Full Text] [Related]

  • 18. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
    Bruner LH, Bull RW, Roth RA.
    Toxicol Appl Pharmacol; 1987 Oct 15; 91(1):1-12. PubMed ID: 3672514
    [Abstract] [Full Text] [Related]

  • 19. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ, Olson JW, Gillespie MN.
    J Pharmacol Exp Ther; 1986 Feb 15; 236(2):390-5. PubMed ID: 3080584
    [Abstract] [Full Text] [Related]

  • 20. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA, Reindel JF.
    Adv Exp Med Biol; 1991 Feb 15; 283():477-87. PubMed ID: 1906225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.